Antibody titers before and after booster doses of SARS-CoV-2 mRNA vaccines in healthy adults | medRxiv

Article usage

Article usage: November 2021 to May 2022

	Abstract	Full	Pdf
Nov 2021	22760	3183	11009
Dec 2021	12188	1749	5061
Jan 2022	8724	363	2303
Feb 2022	4249	144	974
Mar 2022	1639	74	478
Apr 2022	1070	50	308
May 2022	654	43	195

View the discussion thread.

Posted November 21, 2021.

Subject Area

Infectious Diseases (except HIV/AIDS)

Subject Areas

All Articles

Addiction Medicine (163)
Allergy and Immunology (416)
Anesthesia (92)
Cardiovascular Medicine (865)
Dentistry and Oral Medicine (159)
Dermatology (98)
Emergency Medicine (251)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (397)
Epidemiology (8587)
Forensic Medicine (4)
Gastroenterology (390)
Genetic and Genomic Medicine (1765)
Geriatric Medicine (168)
Health Economics (373)
Health Informatics (1250)
Health Policy (624)
Health Systems and Quality Improvement (470)
Hematology (197)
HIV/AIDS (379)
Infectious Diseases (except HIV/AIDS) (10333)
Intensive Care and Critical Care Medicine (553)
Medical Education (192)
Medical Ethics (51)
Nephrology (214)
Neurology (1691)
Nursing (97)
Nutrition (252)
Obstetrics and Gynecology (328)
Occupational and Environmental Health (451)
Oncology (930)
Ophthalmology (264)
Orthopedics (102)
Otolaryngology (172)
Pain Medicine (114)
Palliative Medicine (40)
Pathology (254)
Pediatrics (538)
Pharmacology and Therapeutics (255)
Primary Care Research (209)
Psychiatry and Clinical Psychology (1782)
Public and Global Health (3863)
Radiology and Imaging (626)
Rehabilitation Medicine and Physical Therapy (322)
Respiratory Medicine (522)
Rheumatology (208)
Sexual and Reproductive Health (170)
Sports Medicine (158)
Surgery (191)
Toxicology (36)
Transplantation (101)
Urology (76)